Home LiteratureArticle Details
PMID: 9126740 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Relationship between subjective effects of cocaine and dopamine transporter occupancy.

Nature ·Vol. 386 ·No. 6627 ·1997-04-24 ·Pages 827-30

Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, Vitkun S, Logan J, Gatley SJ, Pappas N, Hitzemann R, Shea CE

Abstract

Cocaine is believed to work by blocking the dopamine transporter (DAT) and thereby increasing the availability of free dopamine within the brain. Although this concept is central to current cocaine research and to treatment development, a direct relationship between DAT blockade and the subjective effects of cocaine has not been demonstrated in humans. We have used positron emission tomography to determine what level of DAT occupancy is required to produce a subjective 'high' in human volunteers who regularly abuse cocaine. We report here that intravenous cocaine at doses commonly abused by humans (0.3-0.6 mg kg(-1)) blocked between 60 and 77% of DAT sites in these subjects. The magnitude of the self-reported high was correlated with the degree of DAT occupancy, and at least 47% of the transporters had to be blocked for subjects to perceive cocaine's effects. Furthermore, the time course for the high paralleled that of cocaine concentration within the striatum, a brain region implicated in the control of motivation and reward. This is the first demonstration in humans that the doses used by cocaine abusers lead to significant blockade of DAT, and that this blockade is associated with the subjective effects of cocaine. Although these findings provide justification to target the DAT for medication development they suggest that for drugs to be effective in blocking cocaine's effects they would have to be given at doses that achieve almost complete DAT occupancy.

MeSH Terms
Adult Binding, Competitive Carrier Proteins/metabolism Cerebellum/drug effects,metabolism Cocaine/metabolism,pharmacokinetics,pharmacology Corpus Striatum/drug effects,metabolism Dopamine Dopamine Plasma Membrane Transport Proteins Dopamine Uptake Inhibitors/metabolism,pharmacokinetics,pharmacology Dose-Response Relationship, Drug Female Humans Male Membrane Glycoproteins Membrane Transport Proteins Nerve Tissue Proteins Self-Assessment Substance Abuse, Intravenous/metabolism,psychology Substance-Related Disorders/metabolism,psychology Tomography, Emission-Computed
Chemicals
Carrier Proteins Dopamine Plasma Membrane Transport Proteins Dopamine Uptake Inhibitors Membrane Glycoproteins Membrane Transport Proteins Nerve Tissue Proteins SLC6A3 protein, human Cocaine Dopamine
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Volkow N D
Medical Department, Brookhaven National Laboratory, Upton, New York 11973, USA.
Wang G J
Fischman M W
Foltin R W
Fowler J S
Abumrad N N
Vitkun S
Logan J
Gatley S J
Pappas N
Hitzemann R
Shea C E
Article Info
Journal
Nature
Abbr.
Nature
ISSN
0028-0836
Published
1997-04-24
Pages
827-30
Language
English
Region
England
NLM ID
0410462
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com